Patents by Inventor James D. Rodgers

James D. Rodgers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUBSTITUTED HETEROCYCLES AS JANUS KINASE INHIBITORS
    Publication number: 20080188500
    Abstract: The present invention provides substituted tricyclic heteroaryl compounds, including, for example, pyridoindoles, pyrimidinoindoles and triazinoindoles that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases such as immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.
    Type: Application
    Filed: December 20, 2007
    Publication date: August 7, 2008
    Inventors: Argyrios G. Arvanitis, James D. Rodgers, Louis Storace, Beverly Folmer
  • Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-4-yl-amines as Janus kinase inhibitors
    Patent number: 7335667
    Abstract: The present invention provides pyrrolo[2,3-b]pyridine-4-yl amines pyrrolo[2,3-b]pyrimidin-4-yl amines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases and cancer.
    Type: Grant
    Filed: December 21, 2005
    Date of Patent: February 26, 2008
    Assignee: Incyte Corporation
    Inventors: James D. Rodgers, Haisheng Wang, Andrew P. Combs, Richard B. Sparks
  • Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors
    Patent number: 6969721
    Abstract: The present invention relates to tricyclic 2-pyridone compounds of formula (I): or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.
    Type: Grant
    Filed: June 10, 2003
    Date of Patent: November 29, 2005
    Assignee: Bristol-Myers Squibb Pharma
    Inventors: James D. Rodgers, Haisheng Wang, Mona Patel, Argyrios Arvanitis, Anthony J. Cocuzza
  • Tricyclic compounds useful as HIV reverse transcriptase inhibitors
    Patent number: 6825210
    Abstract: The present invention relates to tricyclic compounds of formula (I): or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.
    Type: Grant
    Filed: April 17, 2002
    Date of Patent: November 30, 2004
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Barry L. Johnson, James D. Rodgers, Qiyan Lin, Anurag S. Srivastava
  • 2, 4-disubstituted-pyridine N-oxides useful as HIV reverse transcriptase inhibitors
    Patent number: 6809109
    Abstract: The present invention relates to 2,4-disubstituted pyridine-N-oxide compounds of formula (I): or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.
    Type: Grant
    Filed: June 25, 2003
    Date of Patent: October 26, 2004
    Assignee: Bristol-Myers Squibb Company
    Inventors: James D. Rodgers, Haisheng Wang
  • Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors
    Publication number: 20040023955
    Abstract: The present invention relates to tricyclic 2-pyridone compounds of formula (I): 1
    Type: Application
    Filed: June 10, 2003
    Publication date: February 5, 2004
    Inventors: James D. Rodgers, Haisheng Wang, Mona Patel, Argyrios Arvanitis, Anthony J. Cocuzza
  • 2, 4-Disubstituted-pyridine N-oxides useful as HIV reverse transcriptase inhibitors
    Publication number: 20040019047
    Abstract: The present invention relates to 2,4-disubstituted pyridine-N-oxide compounds of formula (I): 1
    Type: Application
    Filed: June 25, 2003
    Publication date: January 29, 2004
    Inventors: James D. Rodgers, Haisheng Wang
  • Tricyclic compounds useful as HIV reverse transcriptase inhibitors
    Publication number: 20040002498
    Abstract: The present invention relates to tricyclic compounds of formula (I): 1
    Type: Application
    Filed: April 24, 2003
    Publication date: January 1, 2004
    Inventors: Barry L. Johnson, Mona Patel, James D. Rodgers, Haisheng Wang, Christine M. Tarby, Rajagopal Bakthavatchalam
  • Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors
    Patent number: 6596729
    Abstract: The present invention relates to tricyclic 2-pyridone compounds of formula (I): or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.
    Type: Grant
    Filed: July 19, 2001
    Date of Patent: July 22, 2003
    Assignee: Bristol-Myers Squibb Company
    Inventors: James D. Rodgers, Haisheng Wang, Mona Patel, Argyrios Arvanitis, Anthony J. Cocuzza
  • Tricyclic compounds useful as HIV reverse transcriptase inhibitors
    Patent number: 6593337
    Abstract: The present invention relates to tricyclic compounds of formula (I): or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.
    Type: Grant
    Filed: October 18, 2000
    Date of Patent: July 15, 2003
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Barry L. Johnson, Mona Patel, James D. Rodgers, Christine M. Tarby, Rajagopal Bakthavatchalam
  • 5, 5-disubstituted-1, 5-dihydro-4, 1-benzoxazepin-2 (3H)-ones useful as HIV reverse transcriptase inhibitors
    Patent number: 6489320
    Abstract: The present invention relates to benzoxazepinones of formula I: or stereoisomeric forms or mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same and methods of using the same for treating viral infection or as an assay standard or reagent.
    Type: Grant
    Filed: September 7, 2000
    Date of Patent: December 3, 2002
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Anthony J. Cocuzza, James D. Rodgers
  • Tricyclic compounds useful as HIV reverse transcriptase inhibitors
    Publication number: 20020177603
    Abstract: The present invention relates to tricyclic compounds of formula (I): 1
    Type: Application
    Filed: April 17, 2002
    Publication date: November 28, 2002
    Inventors: Barry L. Johnson, James D. Rodgers, Qiyan Lin, Anurag S. Srivastava
  • 1,4-benzodiazepin-2-ones useful as HIV reverse transcriptase inhibitors
    Patent number: 6462037
    Abstract: The present invention relates to 1,4-benzodiazepin-2-ones of Formula (I): or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.
    Type: Grant
    Filed: May 25, 2000
    Date of Patent: October 8, 2002
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: James D. Rodgers, Barry L. Johnson, Haisheng Wang
  • Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors
    Publication number: 20020107261
    Abstract: The present invention relates to tricyclic 2-pyridone compounds of formula (I): 1
    Type: Application
    Filed: July 19, 2001
    Publication date: August 8, 2002
    Inventors: James D. Rodgers, Haisheng Wang, Mona Patel, Argyrios Arvanitis, Anthony J. Cocuzza
  • 1-(3-aminoindazol-5-yl)-3-butyl-cyclic urea useful as a HIV protease inhibitor
    Publication number: 20010011088
    Abstract: The present invention relates to compounds of formula I: 1
    Type: Application
    Filed: February 28, 2001
    Publication date: August 2, 2001
    Inventors: James D. Rodgers, Patrick Y. Lam
  • Substituted quinolin-2 (1H) -ones useful as HIV reverse transcriptase inhibitors
    Patent number: 6265406
    Abstract: This invention relates generally to quinolin-2(1H)-ones and derivatives thereof of Formula (I): or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, pharmaceutical compositions and diagnostic kits comprising the same, methods of using the same for treating viral infection or as assay standards or reagents, and intermediates and processes for making the same.
    Type: Grant
    Filed: June 13, 2000
    Date of Patent: July 24, 2001
    Assignee: DuPont Pharmaceuticals Company
    Inventors: Mona Patel, James D. Rodgers
  • 1,3-Benzodiazepin-2-ones and 1,3-Benzoxazepin-2-ones useful as HIV reverse transcriptase inhibitors
    Patent number: 6204262
    Abstract: The present invention relates to 1,3-benzodiazepin-2-ones and 1,3-benzoxazepin-2-ones of formula I: or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.
    Type: Grant
    Filed: June 29, 1999
    Date of Patent: March 20, 2001
    Assignee: DuPont Pharmaceuticals Company
    Inventors: James D. Rodgers, Anthony J. Cocuzza, Donna M. Bilder
  • 5,5-disubstituted-1,5-dihydro-4,1-benzoxazepin-2 (3H)-ones useful as HIV reverse transcriptase inhibitors
    Patent number: 6140320
    Abstract: The present invention relates to benzoxazepinones of formula I: ##STR1## or stereoisomeric forms or mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same and methods of using the same for treating viral infection or as an assay standard or reagent.
    Type: Grant
    Filed: September 1, 1998
    Date of Patent: October 31, 2000
    Assignee: Dupont Pharmaceuticals Company
    Inventors: Anthony J. Cocuzza, James D. Rodgers
  • Substituted quinolin-2 (1H)-ones useful as HIV reverse transcriptase inhibitors
    Patent number: 6090821
    Abstract: This invention relates generally to quinolin-2(1H)-ones and derivatives thereof of Formula (I): ##STR1## or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, pharmaceutical compositions and diagnostic kits comprising the same, methods of using the same for treating viral infection or as assay standards or reagents, and intermediates and processes for making the same.
    Type: Grant
    Filed: June 29, 1999
    Date of Patent: July 18, 2000
    Assignee: E. I. DuPont de Nemours and Company
    Inventors: Mona Patel, James D. Rodgers
  • Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
    Patent number: RE37781
    Abstract: This invention relates to substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors, to pharmaceutical compositions comprising such compounds, and to methods of using these compounds for treating viral infection. A representative compound of the invention is the compound of formula: wherein R22 and R23 are allyl.
    Type: Grant
    Filed: March 10, 1999
    Date of Patent: July 2, 2002
    Assignee: DuPont Pharmaceuticals Company
    Inventors: Patrick Y. Lam, Prabhakar K. Jadhav, Charles J. Eyermann, Carl N. Hodge, George V. De Lucca, James D. Rodgers